On October 7, 2011 -9 at the Beijing National Convention Center held the eighth session of the Asia Pacific Association symposium, the meeti
On October 7, 2011 -9 at the Beijing National Convention Center held the eighth session of the Asia Pacific Association symposium, the meeting of experts at home and abroad on translational medicine: clinical immunology and immunological treatment of viral hepatitis was carried out all-round discussion.
Translational medicine, in 2003 by the United States National Institutes of Health (NIH) formally proposed, and has been increasingly widespread concern in the medical community. In China, translational medicine has become a major national policy in the field of biomedicine, and will be one of the core contents of the medical and health industry during the period of 12th Five-Year
Translational medicine goal is to maximize the elimination of basic medicine and clinical medicine the barrier, shorten the laboratory to the process of clinical application, the basis of the results obtained can be quickly transformed into a drug used to treat patients or medical devices and equipment, let the fruit into - patients directly and quickly benefited from the basic research foundation is the definition of translational medicine. Translational medicine is not simply based on the results of research into clinical practice, it also means that the transformation of the entire medical model. The new medical model is to predict, prevent, early intervention and individualized treatment as the future direction of clinical medicine.
The meeting of experts at home and abroad published in translational medicine liver disease in the field of liver disease: 1 to establish a better cell model and animal model; 2 disease signal transduction pathway in the process; 3 diagnostic biomarkers; 4 for disease specific target.